A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for mirvetuximab soravtansine (an antibody-drug conjugate therapy), emphasizing ...
When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment ...
Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...
We tried out one of the most advanced baseline diagnostic panels available – here’s what we discovered about our health with this biomarker testing… Preventative healthcare has long been the preserve ...
Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...
Integrative clinico-genomic evaluation of the human epidermal growth factor receptor 2 (HER2) in urothelial cancer (UC). EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab ...
Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...
Hosted on MSN
Functional Lab Tests Are Everywhere. But How Many Biomarkers Do You Really Need Tested To Be Healthy?
It may feel nearly impossible to scroll through social media these days without seeing ads for trendy, pricey functional medicine subscription services and at-home tests that promise to unlock key ...
Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic ...
Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...
Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...
U.S. Market Valued at USD 2.17 Billion in 2025 While Europe Reaches USD 1.47 Billion as Biomarker-Based Cancer Testing Expands.Austin, United States, June 08, 2026 (GLOBE NEWSWIRE) -- “The Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results